Table 1 Characteristics of the study population
Characteristics | All (n = 140) | VESD (n = 69) | Controls (n = 71) | p |
|---|---|---|---|---|
Female/Male, n | 54/86 | 27/42 | 27/44 | 1.00 |
Age, years mean (SD) | 74 (11.8) | 75 (11) | 73 (12) | 0.23 |
Stroke subtype, n | ||||
 Ischemic stroke/ Intracerebral haemorrhage | 129/10 (n = 139) | 65/3 (n = 68) | 64/7 | 0.32 |
Localisation, n (%) | ||||
 Right hemisphere | 43 (30.7) | 22 (31.9) | 21 (29.6) |  |
 Left hemisphere | 35 (25.0) | 16 (23.2) | 19 (26.8) |  |
 Unknown | 41 (29.3) | 20 (28.9) | 21 (29.6) |  |
 Bilateral | 7 (5.0) | 4 (5.8) | 3 (4.2) |  |
 Cerebellum | 10 (7.1) | 4 (5.8) | 6 (8.5) |  |
 Brain stem | 4 (2.9) | 3 (4.3) | 1 (1.4) |  |
Treatment, n | ||||
 Thrombolysis/Thrombectomy | 15/6 | 6/3 | 9/3 | 0.58/1.00 |
NIHSSa, median (IQR) | 3 (1–5) (n = 137) | 3 (1–5) (n = 68) | 2 (1–5) (n = 69) | 0.27 |
Hospital stay, median (IQR) | 13 (9–17) | 12 (9–17) | 13 (9–17) | 0.53 |
BBS, median (IQR) | 49, (38–53) | 49 (40–53) | 48 (35–52) | 0.33 |
TUG (s), median (IQR) | 14,6 (11.4–21.9) | 13.5 (10.8–20.0) | 16.3 (11.8–23.1) | 0.21 |
HADS-A, median (IQR) | 4 (1–8) | 4 (1–8) | 4 (2–8) | 0.26 |